180 Life Sciences Corp. Quarterly Nonoperating Income (Expense) in USD from Q3 2017 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
180 Life Sciences Corp. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q3 2017 to Q3 2024.
  • 180 Life Sciences Corp. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $142K.
  • 180 Life Sciences Corp. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $3.24M.
  • 180 Life Sciences Corp. annual Nonoperating Income (Expense) for 2023 was -$8.81M, a 59.5% increase from 2022.
  • 180 Life Sciences Corp. annual Nonoperating Income (Expense) for 2022 was -$21.8M, a 363% decline from 2021.
  • 180 Life Sciences Corp. annual Nonoperating Income (Expense) for 2021 was -$4.71M, a 10.5% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $3.24M $142K +$9.21M Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$5.97M $1.86M +$1.86M Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 -$7.83M $1.02M +$981K +2349% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$8.81M $221K +$17.3M Oct 1, 2023 Dec 31, 2023 10-K 2024-03-25
Q3 2023 -$26.1M -$9.07M +$8.36M +48% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$34.4M $2.81K* -$7.46M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 -$27M $41.8K -$5.2M -99.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$21.8M -$17M -$22.5M -410% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-25
Q3 2022 $766K -$17.4M -$39.9M -177% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $40.7M $7.46M +$26.9M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-15
Q1 2022 $13.8M $5.24M +$18.5M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$4.71M $5.49M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $22.5M +$22.6M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$19.5M -$20.6M -1726% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$13.3M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q3 2020 -$103K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $1.2M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q3 2017 $334K Jul 1, 2017 Sep 30, 2017 10-Q 2017-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.